首页> 外文期刊>Molecular & cellular proteomics: MCP >Experimental Peptide Identification Repository (EPIR): an integrated peptide-centric platform for validation and mining of tandem mass spectrometry data.
【24h】

Experimental Peptide Identification Repository (EPIR): an integrated peptide-centric platform for validation and mining of tandem mass spectrometry data.

机译:实验性肽鉴定储存库(EPIR):一个以肽为中心的集成平台,用于验证和挖掘串联质谱数据。

获取原文
获取原文并翻译 | 示例
           

摘要

LC MS/MS has become an established technology in proteomic studies, and with the maturation of the technology the bottleneck has shifted from data generation to data validation and mining. To address this bottleneck we developed Experimental Peptide Identification Repository (EPIR), which is an integrated software platform for storage, validation, and mining of LC MS/MS-derived peptide evidence. EPIR is a cumulative data repository where precursor ions are linked to peptide assignments and protein associations returned by a search engine (e.g. Mascot, Sequest, or PepSea). Any number of datasets can be parsed into EPIR and subsequently validated and mined using a set of software modules that overlay the database. These include a peptide validation module, a protein grouping module, a generic module for extracting quantitative data, a comparative module, and additional modules for extracting statistical information. In the present study, the utility of EPIR and associated software tools is demonstrated on LC MS/MS data derived from a set of model proteins and complex protein mixtures derived from MCF-7 breast cancer cells. Emphasis is placed on the key strengths of EPIR, including the ability to validate and mine multiple combined datasets, and presentation of protein-level evidence in concise, nonredundant protein groups that are based on shared peptide evidence.
机译:LC MS / MS已成为蛋白质组学研究中的一项成熟技术,随着该技术的成熟,瓶颈已从数据生成转移到数据验证和挖掘。为了解决这个瓶颈,我们开发了实验性肽鉴定库(EPIR),它是用于存储,验证和挖掘LC MS / MS衍生的肽证据的集成软件平台。 EPIR是一个累积数据存储库,其中前体离子与搜索引擎(例如Mascot,Sequest或PepSea)返回的肽分配和蛋白质结合相关联。可以将任意数量的数据集解析为EPIR,然后使用覆盖数据库的一组软件模块进行验证和挖掘。这些模块包括肽段验证模块,蛋白质分组模块,用于提取定量数据的通用模块,比较模块以及用于提取统计信息的其他模块。在本研究中,在源自一组模型蛋白质和源自MCF-7乳腺癌细胞的复杂蛋白质混合物的LC MS / MS数据上证明了EPIR和相关软件工具的实用性。重点放在EPIR的关键优势上,包括验证和挖掘多个组合数据集的能力,以及在基于共享肽证据的简明,非冗余蛋白质组中呈现蛋白质水平的证据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号